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Comorbidities and Treatments in United States Youth with Chronic Musculoskeletal Pain 
 Matthew T. Taylor, Sabrina Gmuca, Alexis Boneparth, L. Nandini Moorthy, Daniel B. 
Horton* 
 
Introduction: Chronic musculoskeletal (MSK) pain has been associated with chronic illnesses 
and high rates of pain medication use, often in referral centers, European populations, or studies 
focused on single drug classes. We aimed to characterize patterns of comorbidities and 
treatments associated with chronic MSK pain in a nationally-representative sample of US youth. 
Methods: We used the National Ambulatory Medical Care Survey (2002-2015) and National 
Hospital Ambulatory Medical Care Survey (2002-2011), which contain cross-sectional data for 
US outpatient visits. The study included all visits for youth age 8-24, excluding those with 
malignancy or sickle cell disease. We compared comorbidities and drugs ordered in visits for 
chronic MSK pain with (1) visits for any reason besides MSK pain and (2) visits for acute MSK 
pain, using chi-square tests and logistic regression, adjusting for several covariates. 
Results: Chronic non-psychiatric diseases were more common among visits for chronic MSK 
pain (32.0%) in comparison to both visits for acute MSK pain (17.9%) and visits for other 
reasons (18.8%). Nonsteroidal anti-inflammatories were less commonly ordered at visits for 
chronic MSK pain in comparison to acute MSK pain (adjusted odds ratio [aOR]: 0.63, 95% CI 
0.50-0.80). Opioids, gabapentinoids, and alternative medicine were each ordered more 
commonly at visits for chronic MSK pain in comparison to visits for acute MSK pain and other 
visits. 
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Conclusion: US youth with chronic MSK were more likely to have chronic non-psychiatric 
medical conditions compared to youth without pain. Additionally, opioids, gabapentinoids, and 
alternative medicine were ordered more often in chronic MSK visits, which warrants further 
study. 
